Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
The Dow Jones uses price weighting, which gives more influence to higher-priced stocks. This note covers the rationale and implications for investors.
25,369 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Bitcoin, Ethereum, and XRP flashed potential buy signals after a wide market drop, according to on-chain analytics. A...
Asset managers reevaluating security are treating safety features as a core lever to stabilize NOI and attract tenant...
Dream Finders Homes is expanding through acquisitions, with Beazer Homes on the table. Analysts now eye KB Home as a ...
Booking.com’s CEO used a Denver tarmac delay to illustrate how a proactive AI travel assistant could reroute trips be...
Crypto exchanges are expanding into US stocks and tokenized equities, launching a two-front challenge to traditional ...
Anthropic moved to disable access to its Fable 5 and Mythos 5 models after a U.S. export controls directive barred fo...
In Q1, Berkshire Hathaway slashed 16 holdings, leaving 26 positions and pushing four top stocks to dominate more than...
Two 2x NVIDIA ETFs, NVDX and NVDL, aim to mirror double daily moves in NVIDIA. This report breaks down how daily comp...
Meta is pulling ahead in the AI talent race as policy headwinds tighten, placing Anthropic on the defensive and rattl...
Federal Reserve Chair Kevin Warsh is signaling a second inflation-fighting tool beyond traditional rate changes. Inve...
SpaceX rolls out a $60 billion bid to acquire Cursor and back new silicon ventures, aiming to tilt the AI hardware la...